Cargando…

Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy

INTRODUCTION: The rate of adverse renal events has been shown to be higher in patients treated with lesinurad plus a xanthine-oxidase inhibitor (XOI) than in patients treated only with a XOI. We reassessed the risks for various adverse renal events from a different perspective and devised a hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez-Ruiz, Fernando, Jansen, Tim L., Tausche, Anne-Kathrin, Richette, Pascal, Lioté, Frédéric, So, Alexander K., Stack, Austin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393267/ https://www.ncbi.nlm.nih.gov/pubmed/30767124 http://dx.doi.org/10.1007/s40744-019-0143-9

Ejemplares similares

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
por: Pérez-Ruiz, Fernando, et al.
Publicado: (2019)

Xanthine oxidase inhibitors and sepsis
por: Ramos, Maria Fátima de Paula, et al.
Publicado: (2018)

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout
por: Terkeltaub, Robert, et al.
Publicado: (2019)

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study
por: Dalbeth, Nicola, et al.
Publicado: (2019)

High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
por: Perez-Ruiz, Fernando, et al.
Publicado: (2020)

Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
por: Katsuyama, Hisayuki, et al.
Publicado: (2019)

Xanthine oxidase inhibitors in ischaemic heart disease
por: Zdrenghea, Mihnea, et al.
Publicado: (2017)

Lesinurad: what the nephrologist should know
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2017)

XANTHINE OXIDASE ACTIVITY IN REGENERATING LIVER
por: Feigelson, Muriel, et al.
Publicado: (1957)

Study of Drug Metabolism by Xanthine Oxidase
por: Zhao, Jing, et al.
Publicado: (2012)

Xanthine Oxidase—A Personal History
por: Hille, Russ
Publicado: (2023)

Xanthine oxidase and aldehyde oxidase contribute to allopurinol metabolism in rats
por: Tayama, Yoshitaka, et al.
Publicado: (2022)

Structure–Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase
por: Zhou, Ling-Yun, et al.
Publicado: (2018)

Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
por: Jordan, Andreas, et al.
Publicado: (2018)

Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
por: Nomura, Johji, et al.
Publicado: (2014)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
por: Higa, Yoshiki, et al.
Publicado: (2023)

The mechanism and significance of the conversion of xanthine dehydrogenase to xanthine oxidase in mammalian secretory gland cells
por: Kusano, Teruo, et al.
Publicado: (2022)

Xanthine Oxidase and Uric Acid in Atrial Fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2012)

The impact of xanthine oxidase (XO) on hemolytic diseases
por: Schmidt, Heidi M., et al.
Publicado: (2018)

Structure–activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor
por: Vitale, Rosa Maria, et al.
Publicado: (2017)

The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
por: Ryu, Dong-Ryeol
Publicado: (2017)

Identification of xanthine oxidase inhibitors through hierarchical virtual screening
por: Yang, Ying, et al.
Publicado: (2020)

Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
por: Saito, Hirotaka, et al.
Publicado: (2021)

Oxidized Resveratrol Metabolites as Potent Antioxidants and Xanthine Oxidase Inhibitors
por: Agbadua, Orinamhe G., et al.
Publicado: (2022)

The development of an effective synthetic route of lesinurad (RDEA594)
por: Meng, Qing, et al.
Publicado: (2017)

Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males
por: Shen, Zancong, et al.
Publicado: (2015)

Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues.
por: Anderson, R. F., et al.
Publicado: (1989)

Inhibition of Xanthine Oxidase-Catalyzed Xanthine and 6-Mercaptopurine Oxidation by Flavonoid Aglycones and Some of Their Conjugates
por: Mohos, Violetta, et al.
Publicado: (2020)

Xanthine oxidase acitivity in progressive spontaneous mammary carcinogenesis.
por: Sheth, N. A., et al.
Publicado: (1968)

Implication of changes in xanthine oxidase activity following hemodialysis
por: Fujioka, Hayato, et al.
Publicado: (2023)

Characterization of an Anti-gout Xanthine Oxidase Inhibitor from Pleurotus ostreatus
por: Jang, In-Taek, et al.
Publicado: (2014)

Screening and Evaluation of Xanthine Oxidase Inhibitors from Gnetum parvifolium in China
por: Tang, Xiaosheng, et al.
Publicado: (2019)

In silico design and synthesis of hesperitin derivatives as new xanthine oxidase inhibitors
por: Malik, Neelam, et al.
Publicado: (2019)

In silico design and synthesis of targeted rutin derivatives as xanthine oxidase inhibitors
por: Malik, Neelam, et al.
Publicado: (2019)

Bis-thiobarbiturates as Promising Xanthine Oxidase Inhibitors: Synthesis and Biological Evaluation
por: Serrano, João L., et al.
Publicado: (2021)

Phloroglucinol Derivatives from Dryopteris crassirhizoma as Potent Xanthine Oxidase Inhibitors
por: Yuk, Heung Joo, et al.
Publicado: (2020)

Novel Reversible Inhibitors of Xanthine Oxidase Targeting the Active Site of the Enzyme
por: Rullo, Rosario, et al.
Publicado: (2023)

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
por: Perez-Ruiz, Fernando, et al.
Publicado: (2016)

Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers
por: Gillen, Michael, et al.
Publicado: (2016)

Patient considerations in the management of gout and role of combination treatment with lesinurad
por: Claus, Liza W, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_krpa4h796t02dscqln6l6gdvff